NCT00931073
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
- Locations
-
- Pfizer Investigational Site Kalamazoo, Michigan, United States
Clinical trial condition
Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.
NCT00931073
NCT00926965
NCT00831506
NCT00654251
NCT00620165
NCT00062569
NCT00788047
NCT00018668
NCT00018291
NCT00075140